Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal viewFrederick W. Thielen, Judith R. Ladestein, Peter M. Hoogerbrugge et al.|European Journal Of Haematology|2020Cited by 42
Health‐related quality of life in patients with steroid‐refractory acute graft‐versus‐host diseaseB Leeneman, Frederick W. Thielen, Hedwig M. Blommestein et al.|European Journal Of Haematology|2023Cited by 2